Puriblood Medical Co., Ltd. (6847.TWO)

TWD 101.5

(-1.93%)

Long Term Debt Summary of Puriblood Medical Co., Ltd.

  • Puriblood Medical Co., Ltd.'s latest annual long term debt in 2023 was 43.7 Million TWD , down -13.93% from previous year.
  • Puriblood Medical Co., Ltd.'s latest quarterly long term debt in 2024 Q2 was 19.34 Million TWD , down 0.0% from previous quarter.
  • Puriblood Medical Co., Ltd. reported annual long term debt of 50.77 Million TWD in 2022, up 90.8% from previous year.
  • Puriblood Medical Co., Ltd. reported annual long term debt of 26.6 Million TWD in 2021, down -13.36% from previous year.
  • Puriblood Medical Co., Ltd. reported quarterly long term debt of 19.34 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • Puriblood Medical Co., Ltd. reported quarterly long term debt of 43.7 Million TWD for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Puriblood Medical Co., Ltd. (2023 - 2019)

Historical Annual Long Term Debt of Puriblood Medical Co., Ltd. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 43.7 Million TWD -13.93%
2022 50.77 Million TWD 90.8%
2021 26.6 Million TWD -13.36%
2020 30.71 Million TWD 7.15%
2019 28.66 Million TWD 0.0%

Peer Long Term Debt Comparison of Puriblood Medical Co., Ltd.

Name Long Term Debt Long Term Debt Difference
BIONET Corp. 6.03 Million TWD -624.006%
DIVA Laboratories, Ltd. - TWD -Infinity%
Genetics Generation Advancement Corp. 10.34 Million TWD -322.436%
Welgene Biotech Co.,Ltd. 118.97 Million TWD 63.268%
TFBS Bioscience Inc. 101.84 Million TWD 57.09%